Rainer Ng
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$7.3MFederal grants as PI10 awards
0Patents grantedNone matched
5Papers75 citations
Federal awards and patents by year
AwardsPatents
10 awards · $7.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 9, 2026 | NIH | SBIR Phase II A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance | $1.0M | BAEBIES, INC. |
| Sep 12, 2025 | NIH | SBIR Phase II A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance | $1.0M | BAEBIES, INC. |
| Dec 17, 2024 | NIH | SBIR Phase II A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance | $300K | BAEBIES, INC. |
| Sep 7, 2022 | NIH | SBIR Phase II Identification of glycosaminoglycans for newborn screening and therapeutic monitoring of mucopolysaccharidoses | $703K | BAEBIES, INC. |
| Sep 15, 2021 | NIH | SBIR Phase II Identification of glycosaminoglycans for newborn screening and therapeutic monitoring of mucopolysaccharidoses | $629K | BAEBIES, INC. |
| Jul 26, 2021 | NIH | SBIR Phase II A Novel Workflow to Screen for Illicit Drug Exposure in Newborns | $673K | BAEBIES, INC. |
| Aug 28, 2020 | NIH | SBIR Phase II Identification of glycosaminoglycans for newborn screening and therapeutic monitoring of mucopolysaccharidoses | $194K | BAEBIES, INC. |
| Aug 20, 2020 | NIH | SBIR Phase II A Low Blood Volume Platform for Global Newborn Screening of Common, Treatable Conditions | $717K | BAEBIES, INC. |
| Aug 7, 2020 | NIH | SBIR Phase II A Novel Workflow to Screen for Illicit Drug Exposure in Newborns | $716K | BAEBIES, INC. |
| Sep 15, 2019 | NIH | SBIR Phase II ALow Blood Volume Platform for Global Newborn Screening of Common, Treatable Conditions | $1.4M | BAEBIES, INC. |
1 patents as inventor
- US BAEBIES, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#136
Awards as PI#141
Patents#505
Companies
- BAEBIES, INC.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.